Literature DB >> 15620481

Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot.

Marijana Baricević1, Dubravko Forcić, Tanja Kosutić Gulija, Renata Jug, Renata Mazuran.   

Abstract

To confirm the genetic stability of the Edmonston-Zagreb vaccine strain, we determined and compared the nucleotide sequences of genuine Edmonston-Zagreb master seed (EZ D22) and current working seed lot (EZ D24 2/99). Sequence analysis and comparison of the two sequences confirmed that these two sequences are the same at the molecular level. The obtained sequences were also compared to reference strains, i.e. Edmonston wild-type (Edmonston Wt) AF266288 and Edmonston-Zagreb (EZ) AF266290 vaccine strain. The sequence of EZ D22 differed from the Edmonston Wt in 32 nucleotides. EZ D22 differed from EZ AF266290 in six nucleotides. Coding substitution at position 441 and two silent substitutions at positions 11999 and 14612 in the L gene are unique to EZ D22. The differences found between EZ from different sources can be a good reason for periodical sequence analysis of the same strain in the hands of different manufactures.

Entities:  

Mesh:

Year:  2005        PMID: 15620481     DOI: 10.1016/j.vaccine.2004.08.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  A highly attenuated measles virus vaccine strain encodes a fully functional C protein.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

2.  Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.

Authors:  Linda J Rennick; Rory D de Vries; Thomas J Carsillo; Ken Lemon; Geert van Amerongen; Martin Ludlow; D Tien Nguyen; Selma Yüksel; R Joyce Verburgh; Paula Haddock; Stephen McQuaid; W Paul Duprex; Rik L de Swart
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

3.  Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector.

Authors:  Amando Zuniga; Mathias Liniger; Teldja Neige Azzouz Morin; René R Marty; Marian Wiegand; Orhan Ilter; Sara Weibel; Martin A Billeter; Marlyse C Knuchel; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

4.  Relaxation of purifying selection on live attenuated vaccine strains of the family Paramyxoviridae.

Authors:  Austin L Hughes
Journal:  Vaccine       Date:  2009-02-03       Impact factor: 3.641

Review 5.  Constraints on the Genetic and Antigenic Variability of Measles Virus.

Authors:  Shannon M Beaty; Benhur Lee
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.